MeiraGTx - Public Comps and Valuation Multiples

MeiraGTx Overview

About MeiraGTx

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Founded

2018

HQ

Employees

425

Website

meiragtx.com

Sectors

Drug Development & Therapeutics
Genomics & Personalized Medicine
BioTech
DeepTech

Financials

LTM Revenue $66.1M

Last FY EBITDA -$122M

EV

$661M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

MeiraGTx Financials

As of August 2025, MeiraGTx reported last 12-month revenue of $66.1M.

In the same period, MeiraGTx generated $52.0M in LTM gross profit and -$120M in net income.

See MeiraGTx valuation multiples based on analyst estimates

MeiraGTx P&L

In the most recent fiscal year, MeiraGTx reported revenue of $33.3M and EBITDA of -$122M.

MeiraGTx expects next 12-month revenue of XXX and NTM EBITDA of XXX

See MeiraGTx valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$66.1M	XXX	$33.3M	XXX	XXX	XXX
Gross Profit	$52.0M	XXX	$9.5M	XXX	XXX	XXX
Gross Margin	79%	XXX	29%	XXX	XXX	XXX
EBITDA	n/a	XXX	-$122M	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	-366%	XXX	XXX	XXX
EBIT	-$128M	XXX	-$164M	XXX	XXX	XXX
EBIT Margin	-193%	XXX	-493%	XXX	XXX	XXX
Net Profit	-$120M	XXX	-$148M	XXX	XXX	XXX
Net Margin	-181%	XXX	-444%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for MeiraGTx including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $66.1M. In the most recent fiscal year, MeiraGTx achieved $33.3M in revenue and -$122M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$66.1M	Analyst estimates available to subscribers	$33.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$52.0M	Analyst estimates available to subscribers	$9.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	78.6% gross margin	Analyst estimates available to subscribers	28.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	n/a	Analyst estimates available to subscribers	-$122M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	n/a	Analyst estimates available to subscribers	-366.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$128M	Analyst estimates available to subscribers	-$164M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-193.0% EBIT margin	Analyst estimates available to subscribers	-493.4% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$120M	Analyst estimates available to subscribers	-$148M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-180.9% net profit margin	Analyst estimates available to subscribers	-444.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for MeiraGTx

This financial data table provides comprehensive performance metrics for MeiraGTx, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

MeiraGTx generated $66.1M in revenue over the last twelve months.
Gross profit for the last twelve months was $52.0M.
Net income over the last twelve months reached -$120M.

Fiscal Year Performance

In the most recent fiscal year, MeiraGTx reported $33.3M in total revenue.
Fiscal year EBITDA was -$122M.
The company maintained a gross profit margin of 28.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was -366.1%.
Net profit margin reached -444.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for MeiraGTx. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

MeiraGTx Stock Performance

MeiraGTx has current market cap of $612M, and EV of $661M.

Market Cap Evolution

MeiraGTx Stock Data

As of September 12, 2025, MeiraGTx's stock price is $8.

See MeiraGTx trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$661M	$612M	XXX	XXX	XXX	XXX	$-1.32

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

MeiraGTx Valuation Multiples

MeiraGTx's trades at 19.8x EV/Revenue multiple, and -5.4x EV/EBITDA.

See valuation multiples for MeiraGTx and 15K+ public comps

MeiraGTx Financial Valuation Multiples

As of September 12, 2025, MeiraGTx has market cap of $612M and EV of $661M.

Equity research analysts estimate MeiraGTx's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

MeiraGTx has a P/E ratio of -5.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$612M	XXX	$612M	XXX	XXX	XXX
EV (current)	$661M	XXX	$661M	XXX	XXX	XXX
EV/Revenue	10.0x	XXX	19.8x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	-5.4x	XXX	XXX	XXX
EV/EBIT	-5.2x	XXX	-4.0x	XXX	XXX	XXX
EV/Gross Profit	12.7x	XXX	n/a	XXX	XXX	XXX
P/E	-5.1x	XXX	-4.1x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-6.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get MeiraGTx Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

MeiraGTx Margins & Growth Rates

MeiraGTx's last 12 month revenue growth is 164%

MeiraGTx's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.4M for the same period.

MeiraGTx's rule of 40 is -243% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

MeiraGTx's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for MeiraGTx and other 15K+ public comps

MeiraGTx Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	164%	XXX	154%	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	-366%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	-243%	XXX	-202%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.4M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	359%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	522%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial